These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2646056)

  • 1. Emerging role of quinolones in the prevention of gram-negative bacteremia in neutropenic cancer patients and in the treatment of enteric infections.
    Bow EJ; Louie TJ
    Clin Invest Med; 1989 Feb; 12(1):61-8. PubMed ID: 2646056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention of bacterial and fungal infections in neutropenic patients with malignant hematologic diseases].
    Candoni A; Russo D; Salmaso F
    Clin Ter; 1997; 148(1-2):23-8. PubMed ID: 9377834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The place of quinolones in bacterial infections.
    Neu HC
    Adv Intern Med; 1991; 36():1-32. PubMed ID: 2024577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prophylaxis with fluoroquinolones in patients with neutropenia].
    Brodsky AL; Minissale CJ; Melero MJ; Sánchez Avalos JC
    Medicina (B Aires); 1993; 53(5):401-7. PubMed ID: 8201928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection management during antileukemia treatment-induced granulocytopenia: the role for oral norfloxacin prophylaxis against infections arising from the gastrointestinal tract.
    Karp JE; Merz WG; Hendricksen C; Laughon B; Redden T; Bamberger BJ; Bartlett JG; Saral R; Burke PJ
    Scand J Infect Dis Suppl; 1986; 48():66-78. PubMed ID: 3535055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The spectrum of Gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against Gram-positive bacteria isolated from cancer patients.
    Rolston KV; Yadegarynia D; Kontoyiannis DP; Raad II; Ho DH
    Int J Infect Dis; 2006 May; 10(3):223-30. PubMed ID: 16439177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprophylaxis of gram-negative infections in neutropenic patients.
    Klastersky J
    Eur Urol; 1990; 17 Suppl 1():40-5. PubMed ID: 2162299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis of bacterial infections with oral antibiotics in neutropenic patients. Lessons from the last two EORTC trials and prospects for the future.
    Zinner SH
    Schweiz Med Wochenschr Suppl; 1983; 14():7-14. PubMed ID: 6361995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of quinolones as therapy in granulocytopenic cancer patients. Comparison with other antimicrobials.
    Krcméry V
    Drugs; 1995; 49 Suppl 2():139-43. PubMed ID: 8549284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prophylaxis using quinolones in neutropenic patients. Preliminary results of a cooperative study by the Grupo Italiano Malattie Ematologiche maligne dell'adulto (GIMEMEA)].
    Del Favero A; Martino P; Bucaneve G; Micozzi A; D'Antonio D; Minetti B; Ricci P; Landonio G; Montillo M; Malleo C
    Haematologica; 1989 Oct; 74(5 Suppl):278-86. PubMed ID: 2512214
    [No Abstract]   [Full Text] [Related]  

  • 11. New drugs for infections in patients with cancer.
    Hughes WT
    Cancer; 1992 Aug; 70(4 Suppl):959-65. PubMed ID: 1322231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocompromised animal models for the study of antibiotic combinations.
    Calandra T; Glauser MP
    Am J Med; 1986 May; 80(5C):45-52. PubMed ID: 3087166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
    Tamura K
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of infections in granulocytopenic patients by fluorinated quinolones.
    Rozenberg-Arska M; Dekker AW; Verhoef J
    Rev Infect Dis; 1989; 11 Suppl 5():S1231-6. PubMed ID: 2672251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of the fluoroquinolone antibiotics.
    Just PM
    Pharmacotherapy; 1993; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.
    Reuter S; Kern WV; Sigge A; Döhner H; Marre R; Kern P; von Baum H
    Clin Infect Dis; 2005 Apr; 40(8):1087-93. PubMed ID: 15791505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and effects on bowel and throat microflora of oral levofloxacin as antibacterial prophylaxis in neutropenic patients with haematological malignancies.
    Timmers GJ; Dijstelbloem Y; Simoons-Smit AM; van Winkelhoff AJ; Touw DJ; Vandenbroucke-Grauls CM; Huijgens PC
    Bone Marrow Transplant; 2004 Apr; 33(8):847-53. PubMed ID: 14755314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic infection and colonization with and without prophylactic norfloxacin use over time in the granulocytopenic, acute leukemia patient.
    Karp JE; Dick JD; Merz WG
    Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S5-13. PubMed ID: 3127219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of norfloxacin and pefloxacin in the prophylaxis of bacterial infection in neutropenic cancer patients.
    D'Antonio D; Iacone A; Fioritoni G; Betti S; Dell'Isola M; Quaglietta AM; Accorsi P; Pantalone V; Recchia A; Piergallini A
    Drugs Exp Clin Res; 1992; 18(4):141-6. PubMed ID: 1451644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empiric antibiotic therapy for granulocytopenic cancer patients.
    Schimpff SC
    Am J Med; 1986 May; 80(5C):13-20. PubMed ID: 3521270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.